A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

123 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-31

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter retrospective study to investigate the dosage regimens of sertraline in the treatment of Posttraumatic Stress Disorder (PTSD) under current medical practice and the efficacy and safety of this drug in patients with PTSD. Data will be collected from the medical records of patients with PTSD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD

NCT00150306

Stress Disorders, Post-Traumatic

TERMINATED PHASE3

A Study of Sertraline to Prevent PTSD

NCT00182078

Posttraumatic Stress Disorder Depression

COMPLETED PHASE4

The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram

NCT00179257

Major Depressive Disorder

COMPLETED PHASE3

Evaluation of Stress Disorders

NCT00050804

Acute Traumatic Stress Disorders Post-Traumatic Stress Disorders

COMPLETED PHASE4

Predicting SSRI Efficacy in Veterans With PTSD

NCT04183205

Posttraumatic Stress Disorder Major Depressive Disorder

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with PTSD who have been dosed with sertraline from July 2006 (i.e., the start of marketing of this drug in Japan) or later to before contracting with each investigational site.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posttraumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sertraline (Zoloft)

Intervention Type DRUG

Dosage form: Tablet, Dosage: over 25 mg/day, duration: Not defined

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sertraline (Zoloft)

Dosage form: Tablet, Dosage: over 25 mg/day, duration: Not defined

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with PTSD who have been dosed with sertraline since July 2006 or later.
* Patients must be Japanese.
* Patients should be started before the conclusion of a contract with each investigational site.